Complete Filing Data
Immunome Inc. reported Stockholders Equity of $634.34 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Immunome Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$212.4M | -$293.0M | -$106.8M | -$36.9M | -$24.7M | -$17.8M | -$10.4M |
| Research And Development Expense | $177.3M | $129.5M | $23.1M | $23.3M | $14.1M | $7.5M | $8.8M |
| Operating Income Loss | -$224.1M | -$305.8M | -$109.5M | -$36.9M | -$25.2M | -$12.3M | -$10.3M |
| Operating Expenses | $231.1M | $314.8M | $123.5M | $36.9M | $25.2M | $12.3M | $10.3M |
| Interest Income Expense Net | $11.7M | $12.8M | $2.7M | $5.0K | -$10.0K | -$38.0K | -$96.0K |
| General And Administrative Expense | $43.8M | $33.0M | $19.7M | $13.6M | $11.1M | $4.8M | $1.5M |
| Net Income Loss Available To Common Stockholders Basic | -$212.4M | -$293.0M | -$106.8M | -$37.5M | -$24.7M | ||
| Revenue From Contract With Customer Excluding Assessed Tax | $6.9M | $9.0M | $14.0M | ||||
| Comprehensive Income Net Of Tax | -$212.5M | -$292.9M | -$106.8M | -$37.5M | |||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$57.0K | $35.0K | $22.0K | ||||
| In Process Research And Development Expense | $10.0M | $152.3M | $80.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$57.5M | -$43.4M | -$41.6M | -$47.1M | -$36.1M | -$129.5M | -$4.3M | -$5.6M | -$4.3M | -$8.5M | -$8.9M | -$11.7M | -$7.7M | -$5.2M | -$3.9M | -$8.4M | -$2.7M | -$2.7M | -$2.7M |
| Research And Development Expense | $49.2M | $40.5M | $36.9M | $37.2M | $29.1M | $15.4M | $3.8M | $5.7M | $3.9M | $5.2M | $5.7M | $8.1M | $4.5M | $3.2M | $2.0M | $1.6M | $1.9M | $2.1M | $2.2M |
| Operating Income Loss | -$60.1M | -$46.5M | -$44.6M | -$50.5M | -$40.0M | -$132.3M | -$4.6M | -$5.8M | -$4.5M | -$8.5M | -$8.9M | -$11.7M | -$7.7M | -$5.7M | -$3.9M | -$2.8M | -$2.7M | -$2.7M | -$2.7M |
| Operating Expenses | $60.1M | $50.5M | $47.6M | $53.4M | $42.4M | $133.3M | $8.2M | $10.0M | $6.8M | $8.5M | $8.9M | $11.7M | $7.7M | $5.7M | $3.9M | $2.8M | $2.7M | $2.7M | $2.7M |
| Interest Income Expense Net | $2.7M | $3.1M | $3.0M | $3.4M | $3.9M | $2.8M | $288.0K | $216.0K | $201.0K | $1.0K | $2.0K | $1.0K | -$3.0K | -$1.0K | -$1.0K | -$10.0K | $5.0K | -$22.0K | -$17.0K |
| General And Administrative Expense | $10.9M | $10.0M | $10.7M | $9.5M | $7.0M | $6.0M | $4.4M | $4.3M | $2.9M | $3.3M | $3.2M | $3.6M | $3.2M | $2.5M | $1.9M | $1.2M | $823.0K | $540.0K | $486.0K |
| Net Income Loss Available To Common Stockholders Basic | -$57.5M | -$43.4M | -$41.6M | -$47.1M | -$36.1M | -$129.5M | -$4.3M | -$5.6M | -$4.3M | -$9.2M | -$7.7M | ||||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $4.0M | $2.9M | $2.9M | $2.4M | $1.0M | $3.6M | $4.3M | $2.4M | ||||||||||
| Comprehensive Income Net Of Tax | -$57.4M | -$43.4M | -$41.7M | -$47.0M | -$36.1M | -$129.5M | -$4.3M | -$5.6M | -$4.3M | ||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $24.0K | -$21.0K | -$60.0K | $68.0K | -$2.0K | -$18.0K | |||||||||||||
| In Process Research And Development Expense | $0.00 | $0.00 | $6.7M | $6.3M | $112.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $634.3M | $181.2M | $119.9M | $16.7M | $48.2M | $41.3M | -$35.6M | -$25.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $653.7M | $143.5M | $98.8M | $20.4M | $49.3M | $39.9M | $2.6M | $1.7M |
| Restricted Cash Noncurrent | $210.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | |
| Cash And Cash Equivalents At Carrying Value | $653.5M | $143.4M | $98.7M | $20.3M | $49.2M | $39.8M | $2.5M | |
| Retained Earnings Accumulated Deficit | -$728.2M | -$515.8M | -$222.8M | -$116.0M | -$79.1M | -$54.4M | -$36.6M | |
| Property Plant And Equipment Net | $14.6M | $10.1M | $2.1M | $681.0K | $855.0K | $1.5M | $1.7M | |
| Liabilities Current | $45.0M | $54.3M | $21.8M | $7.3M | $9.7M | $3.0M | $1.7M | |
| Liabilities And Stockholders Equity | $683.2M | $240.2M | $148.5M | $24.0M | $57.9M | $44.5M | $5.1M | |
| Liabilities | $48.8M | $59.1M | $28.7M | $7.4M | $9.7M | $3.2M | $1.8M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $510.2M | $44.7M | $78.4M | -$28.9M | $9.5M | $37.2M | $941.0K | |
| Assets Current | $660.8M | $221.3M | $144.7M | $22.6M | $56.6M | $42.9M | $3.1M | |
| Assets | $683.2M | $240.2M | $148.5M | $24.0M | $57.9M | $44.5M | $5.1M | |
| Accrued Liabilities And Other Liabilities | $41.7M | $33.2M | $8.0M | $4.9M | $6.7M | $1.4M | $666.0K | |
| Accounts Payable Current | $3.3M | $14.2M | $3.3M | $2.4M | $3.1M | $1.2M | $548.0K | |
| Common Stock Value | $11.0K | $6.0K | $4.0K | $1.0K | $1.0K | $1.0K | ||
| Prepaid Expense And Other Assets Current | $7.3M | $4.0M | $6.6M | $2.3M | $7.4M | $3.1M | ||
| Operating Lease Right Of Use Asset | $3.0M | $4.3M | $1.6M | $284.0K | $500.0K | |||
| Operating Lease Right Of Use Asset Amortization Expense | $489.0K | $535.0K | $271.0K | $209.0K | ||||
| Other Assets Noncurrent | $4.6M | $4.4M | $100.0K | $138.0K | ||||
| Contract With Customer Liability Current | $0.00 | $6.9M | $10.5M | |||||
| Deferred Costs | $332.0K | $332.0K | ||||||
| Available For Sale Securities Debt Securities Current | $0.00 | $74.0M | $39.5M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $0.00 | $57.0K | $22.0K | |||||
| Operating Lease Liability Noncurrent | $3.9M | $4.8M | $1.3M | |||||
| Deferred Rent | $4.0K | -$2.0K | $3.0K | |||||
| Accretion Amortization Of Discounts And Premiums Investments | $2.8M | $2.9M | $512.0K | |||||
| Other Liabilities Noncurrent | $1.3M | $62.0K | $12.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $263.9M | $269.3M | $307.1M | $214.9M | $253.8M | $285.6M | $6.1M | $9.3M | $13.9M | $23.1M | $30.3M | $37.9M | $54.8M | $60.6M | $37.9M | -$49.1M | -$40.8M | -$38.2M | -$32.7M | -$30.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $272.8M | $144.1M | $257.7M | $155.7M | $165.4M | $269.8M | $90.7M | $38.5M | $44.5M | $27.2M | $34.7M | $43.0M | $56.3M | $59.9M | $36.4M | $6.8M | $9.9M | $1.4M | $860.0K | |
| Restricted Cash Noncurrent | $210.0K | $210.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | |||
| Cash And Cash Equivalents At Carrying Value | $272.6M | $143.9M | $257.6M | $155.6M | $165.3M | $269.7M | $90.6M | $38.4M | $44.4M | $27.1M | $34.6M | $42.9M | $56.2M | $59.8M | $36.3M | $6.7M | $9.8M | |||
| Retained Earnings Accumulated Deficit | -$658.3M | -$600.8M | -$557.4M | -$435.5M | -$388.4M | -$352.3M | -$130.2M | -$125.8M | -$120.3M | -$108.2M | -$99.7M | -$90.8M | -$71.3M | -$63.5M | -$58.3M | -$50.3M | ||||
| Property Plant And Equipment Net | $11.6M | $11.0M | $11.0M | $7.2M | $6.1M | $4.3M | $1.2M | $1.2M | $916.0K | $704.0K | $807.0K | $753.0K | $961.0K | $1.2M | $1.4M | $1.7M | ||||
| Liabilities Current | $31.4M | $22.9M | $30.8M | $39.5M | $39.9M | $30.8M | $23.1M | $26.4M | $24.8M | $7.4M | $8.6M | $9.7M | $7.8M | $3.5M | $4.6M | $5.4M | ||||
| Liabilities And Stockholders Equity | $299.4M | $296.3M | $342.7M | $256.9M | $296.2M | $319.8M | $93.2M | $41.4M | $48.1M | $30.5M | $39.0M | $47.7M | $62.6M | $64.1M | $42.6M | $12.0M | ||||
| Liabilities | $35.5M | $27.0M | $35.6M | $42.0M | $42.4M | $34.2M | $87.1M | $32.1M | $34.3M | $7.5M | $8.7M | $9.9M | $7.8M | $3.5M | $4.7M | $12.7M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $114.3M | $171.0M | $24.1M | -$6.4M | -$3.5M | -$1.3M | ||||||||||||||
| Assets Current | $279.9M | $277.4M | $323.1M | $244.0M | $284.3M | $313.3M | $91.4M | $39.5M | $46.5M | $29.2M | $37.6M | $46.3M | $61.2M | $62.8M | $41.1M | $7.5M | ||||
| Assets | $299.4M | $296.3M | $342.7M | $256.9M | $296.2M | $319.8M | $93.2M | $41.4M | $48.1M | $30.5M | $39.0M | $47.7M | $62.6M | $64.1M | $42.6M | $12.0M | ||||
| Accrued Liabilities And Other Liabilities | $25.3M | $18.2M | $17.7M | $26.3M | $20.3M | $10.8M | $3.4M | $5.0M | $3.3M | $4.2M | $3.4M | $5.8M | $4.5M | $1.7M | $1.2M | $2.3M | ||||
| Accounts Payable Current | $6.1M | $4.7M | $9.1M | $3.5M | $7.0M | $7.2M | $2.8M | $3.7M | $3.3M | $3.1M | $5.3M | $3.9M | $3.3M | $1.8M | $3.0M | $2.6M | ||||
| Common Stock Value | $9.0K | $9.0K | $9.0K | $6.0K | $6.0K | $6.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |||||
| Prepaid Expense And Other Assets Current | $7.3M | $9.4M | $5.8M | $3.9M | $5.9M | $3.6M | $773.0K | $1.1M | $2.1M | $2.2M | $2.9M | $3.4M | ||||||||
| Operating Lease Right Of Use Asset | $3.1M | $3.3M | $4.2M | $2.4M | $2.5M | $1.5M | $345.0K | $174.0K | $230.0K | $171.0K | $182.0K | $190.0K | ||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $115.0K | $106.0K | $54.0K | $25.0K | ||||||||||||||||
| Other Assets Noncurrent | $4.6M | $4.4M | $4.3M | $3.2M | $3.2M | $568.0K | $2.7M | |||||||||||||
| Contract With Customer Liability Current | $0.00 | $0.00 | $4.0M | $9.7M | $12.6M | $12.7M | $17.0M | $17.7M | $18.2M | |||||||||||
| Deferred Costs | $130.0K | $432.0K | $332.0K | $332.0K | $332.0K | $382.0K | $307.0K | |||||||||||||
| Available For Sale Securities Debt Securities Current | $0.00 | $124.2M | $59.7M | $84.6M | $113.0M | $40.0M | ||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $0.00 | -$24.0K | -$3.0K | $70.0K | $2.0K | $4.0K | ||||||||||||||
| Operating Lease Liability Noncurrent | $4.0M | $4.1M | $4.8M | $2.5M | $2.5M | $1.2M | ||||||||||||||
| Deferred Rent | -$12.0K | -$1.0K | ||||||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $818.0K | $538.0K | ||||||||||||||||||
| Other Liabilities Noncurrent | $122.0K | $93.0K | $124.0K | $147.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $25.7M | $15.7M | $6.2M | $5.3M | $3.4M | $621.0K | $14.0K |
| Payments To Acquire Property Plant And Equipment | $9.7M | $7.2M | $831.0K | $248.0K | $79.0K | $586.0K | $233.0K |
| Net Cash Provided By Used In Operating Activities | -$190.9M | -$110.8M | -$7.6M | -$28.7M | -$18.2M | -$12.1M | -$9.6M |
| Net Cash Provided By Used In Investing Activities | $60.8M | -$85.1M | -$30.5M | -$248.0K | -$79.0K | -$586.0K | -$233.0K |
| Net Cash Provided By Used In Financing Activities | $640.4M | $240.5M | $116.4M | $32.0K | $27.8M | $49.9M | $10.8M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $3.5M | -$906.0K | $4.1M | -$5.1M | $4.3M | $2.4M | $53.0K |
| Increase Decrease In Accrued Expenses And Other Current Liabilities | $4.5M | $13.6M | $614.0K | -$1.9M | $5.3M | $698.0K | $190.0K |
| Increase Decrease In Accounts Payable | -$9.2M | $9.5M | -$608.0K | -$677.0K | $1.8M | $504.0K | $75.0K |
| Depreciation Depletion And Amortization | $2.5M | $1.6M | $457.0K | $422.0K | $755.0K | $755.0K | $615.0K |
| Proceeds From Stock Options Exercised | $913.0K | $2.0M | $371.0K | $32.0K | $99.0K | $20.0K | $5.0K |
| Proceeds From Issuance Of Common Stock | $45.9M | $20.0M | $34.0K | $1.3M | $44.9M | ||
| Increase Decrease In Contract With Customer Liability | -$6.9M | -$9.0M | $16.0M | ||||
| Increase Decrease In Operating Lease Liability | -$166.0K | -$67.0K | $153.0K | ||||
| Proceeds From Warrant Exercises | $0.00 | $3.7M | |||||
| Proceeds From Public Offering | $633.0M | $230.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q2 2024 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q3 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $5.7M | $2.2M | $1.2M | $1.3M | $325.0K | $146.0K | ||
| Payments To Acquire Property Plant And Equipment | $3.7M | $2.2M | $106.0K | $6.0K | $31.0K | $55.0K | ||
| Net Cash Provided By Used In Operating Activities | -$53.1M | -$11.2M | $24.2M | -$6.4M | -$3.5M | -$2.1M | ||
| Net Cash Provided By Used In Investing Activities | $5.1M | -$37.2M | -$106.0K | -$6.0K | -$31.0K | -$55.0K | ||
| Net Cash Provided By Used In Financing Activities | $162.2M | $219.4M | $34.0K | $32.0K | $76.0K | $844.0K | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.7M | -$2.5M | -$214.0K | -$4.0M | $1.7M | -$99.0K | ||
| Increase Decrease In Accrued Expenses And Other Current Liabilities | -$8.5M | $669.0K | -$1.4M | -$912.0K | -$205.0K | -$109.0K | ||
| Increase Decrease In Accounts Payable | -$3.8M | $2.4M | $687.0K | $788.0K | $1.8M | $314.0K | ||
| Depreciation Depletion And Amortization | $611.0K | $157.0K | $94.0K | $111.0K | $176.0K | $163.0K | ||
| Proceeds From Stock Options Exercised | $213.0K | $171.0K | $32.0K | $6.0K | ||||
| Proceeds From Issuance Of Common Stock | $34.0K | $105.0K | $41.7M | |||||
| Increase Decrease In Contract With Customer Liability | -$2.9M | -$1.0M | $27.6M | |||||
| Increase Decrease In Operating Lease Liability | -$62.0K | -$25.0K | -$62.0K | |||||
| Proceeds From Warrant Exercises | $300.0K | $3.4M | ||||||
| Proceeds From Public Offering | $172.5M | $230.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$2.43 | -$5.00 | -$5.38 | -$3.09 | -$2.14 | -$5.26 | -$9.55 |
| Weighted Average Number Of Shares Outstanding Basic | 87.4M | 58.6M | 19.8M | 12.1M | 11.5M | 3.4M | |
| Weighted Average Number Of Diluted Shares Outstanding | 87.4M | 58.6M | 19.8M | 12.1M | 11.5M | 3.4M | |
| Earnings Per Share Basic | $-2.43 | $-5.00 | $-5.38 | $-3.09 | $-2.14 | $-5.26 | |
| Common Stock Shares Outstanding | 113.1M | 64.5M | 43.3M | 12.1M | 12.1M | 10.6M | 1.1M |
| Common Stock Shares Issued | 113.1M | 64.5M | 43.3M | 12.1M | 12.1M | 10.6M | 1.1M |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 200.0M | 200.0M | 200.0M | 50.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 3.4M | 1.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.65 | -$0.50 | -$0.52 | -$0.78 | -$0.60 | -$2.51 | -$0.36 | -$0.46 | -$0.35 | -$0.75 | -$0.74 | -$0.96 | -$0.65 | -$0.46 | -$0.37 | -$7.52 | -$2.45 | -$2.44 | -$2.50 |
| Weighted Average Number Of Shares Outstanding Basic | 88.0M | 87.0M | 79.4M | 60.2M | 59.9M | 51.5M | 12.2M | 12.2M | 12.2M | 12.1M | 12.1M | 12.1M | 11.9M | 11.5M | 10.6M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 88.0M | 87.0M | 79.4M | 60.2M | 59.9M | 51.5M | 12.2M | 12.2M | 12.2M | 12.1M | 12.1M | 12.1M | 11.9M | 11.5M | 10.6M | ||||
| Earnings Per Share Basic | $-0.65 | $-0.50 | $-0.52 | $-0.78 | $-0.60 | $-2.51 | $-0.36 | $-0.46 | $-0.35 | $-0.75 | $-0.74 | $-0.96 | $-0.65 | $-0.46 | $-0.37 | ||||
| Common Stock Shares Outstanding | 91.7M | 87.0M | 87.0M | 60.4M | 60.0M | 59.7M | 12.2M | 12.2M | 12.2M | 12.1M | 12.1M | 12.1M | 12.1M | 11.8M | 10.7M | 1.1M | |||
| Common Stock Shares Issued | 91.7M | 87.0M | 87.0M | 60.4M | 60.0M | 59.7M | 12.2M | 12.2M | 12.2M | 12.1M | 12.1M | 12.1M | 12.1M | 11.8M | 10.7M | 1.1M | |||
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 65.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 11.9M | 11.5M | 10.6M | 1.1M | 1.1M | 1.1M | 1.1M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $25.7M | $15.7M | $6.2M | $5.3M | $3.4M | $621.0K | $14.0K |
| Stock Issued During Period Value Stock Options Exercised | $913.0K | $2.0M | $371.0K | $32.0K | $20.0K | $5.0K | |
| Additional Paid In Capital | $1.36B | $696.9M | $342.7M | $132.7M | $127.3M | $95.7M | $927.0K |
| Capital Expenditures Incurred But Not Yet Paid | $1.0M | $2.8M | $372.0K | ||||
| Payment Of Offering Costs | $39.5M | $15.2M | $9.0M | $222.0K | |||
| Adjustments To Additional Paid In Capital Warrant Issued | $1.3M | $7.1M | |||||
| Repayments Of Equipment Loan | $113.0K | $212.0K | $225.0K | ||||
| Stock Issued During Period Value New Issues | $221.0K | $38.7M | |||||
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | $70.0K | ||||||
| Stock Issued During Period Value Stock Warrants Exercised | $3.7M | ||||||
| Stock Issued During Period Shares Stock Options Exercised | 389.5K | 769.4K | 651.2K | 18.5K | |||
| Interest Paid Net | $14.0K | $29.0K | $106.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $6.7M | $5.3M | $5.7M | $4.9M | $3.2M | $2.2M | $1.1M | $998.0K | $1.2M | $1.3M | $1.3M | $1.3M | $1.2M | $749.0K | $325.0K | $117.0K | $39.0K | $146.0K | $1.0K |
| Stock Issued During Period Value Stock Options Exercised | $411.0K | $215.0K | $213.0K | $509.0K | $859.0K | $171.0K | $32.0K | $47.0K | $21.0K | $6.0K | $4.0K | $3.0K | |||||||
| Additional Paid In Capital | $922.2M | $870.1M | $864.5M | $650.4M | $642.3M | $637.9M | $136.2M | $135.2M | $134.1M | $131.3M | $130.0M | $128.6M | $126.0M | $124.1M | $96.2M | $1.2M | |||
| Capital Expenditures Incurred But Not Yet Paid | $592.0K | $594.0K | $223.0K | $3.0K | |||||||||||||||
| Payment Of Offering Costs | $10.5M | $14.2M | |||||||||||||||||
| Adjustments To Additional Paid In Capital Warrant Issued | $432.0K | $801.0K | $105.0K | $4.0K | |||||||||||||||
| Repayments Of Equipment Loan | $35.0K | $55.0K | |||||||||||||||||
| Stock Issued During Period Value New Issues | $161.7M | $215.4M | $221.0K | ||||||||||||||||
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | $11.0K | $35.0K | $24.0K | ||||||||||||||||
| Stock Issued During Period Value Stock Warrants Exercised | $304.0K | $3.4M | |||||||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 256.1K | 137.1K | |||||||||||||||||
| Interest Paid Net | $2.0K | $13.0K |
Most recent annual filing with the SEC: March 3, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.